Pharma Events in the UAE: How HCP Engagement Is Going Digital-First 

A New Era for HCP Engagement in the UAE 

The way in which the pharma industry interacts with healthcare professionals (HCPs) in the United Arab Emirates (UAE) is evolving due to an increase in digital engagement from medical companies. Historically, most of the engagement between HCPs and the pharma industry took place with face-to-face interactions at conferences and scientific meetings. However, with an increasing number of HCPs using digital channels as the first point of contact with healthcare products, they now expect more value, credibility and convenience regarding their digital engagement. 

As such, pharma companies are re-evaluating their approach to providing HCPs with an experience, conveying scientific content, and building rapport. The evolution of HCP engagement has been further accelerated by the UAE’s historically professional and progressive healthcare system combined with the recent acceleration of digital adoption, which is changing how HCPs learn about, interact with and assess the validity of information. Today’s leading pharma events include the use of pre-event content, personalization at the event, and post-event learning pathways, which provide HCPs with a continuous experience as opposed to a one-time conference. 

This shift reflects a broader change in how events operate across the UAE, where experience-led, technology-enabled engagement has become the foundation for brand credibility and trust. 

Scientific Content Is Now Delivered Digitally First 

Technology has created a greater reliance on digital technology as it relates to the delivery of scientific education, and this trend will only continue to grow as we move into a more virtual environment. As HCPs become increasingly reliant on digital platforms to receive information before actually showing up to an event, it is changing how companies create the content for their events.  

Micro-learning modules (MLMs) are designed for physicians and specialists so that they can prepare themselves with fundamental knowledge regarding specific topics before coming to an event. The pieces of content provide a summary of research conducted and highlight relevant findings pertaining to the area of study without overloading busy medical professionals with information. Previews of sessions allow HCPs to understand what to expect in each session, giving them an opportunity to determine the order of sessions based on the sessions that apply to their specialty areas.  

Artificial Intelligence (AI) is also a critical tool in this process. AI tools consider the behaviour of HCPs as well as the specialty areas in which they work so that AI content engines provide suggestions for each HCP on what to read, watch and experience prior to an event. For example: a Cardiologist will receive different pre-event content compared to a Dermatologist; and physicians working with new drug classes will receive MLMs tailored specifically to those drug classes. By having access to the relevant information prior to their arrival at the event, each of these physicians will arrive at the venue prepared and ready for deeper discussions about the scientific principles they will be discussing at the event.  

This shift towards a digital first approach to the delivery of scientific education provides an opportunity to produce higher quality attendance at events, as well as ensuring that time spent at the event is not wasted on having to catch up on information. 

Data-Driven Personalization for HCPs 

The medical communities in Dubai, Abu Dhabi, and the greater UAE are amongst the most diverse in the world with specialty physicians coming from myriad healthcare systems with unique training experiences and different subspecialty focus. A single agenda across the board is no longer possible.  

Digital platforms allow pharmaceutical brands to develop customised session tracks based on specialty, history of attending previous events, and personal learning history. Health care professionals (HCPs) now receive customised tracks for the events they attend instead of having to navigate through countless session listings to find value around their clinical interests.  

Likewise, intelligence-based recommendations now direct HCPs to relevant exhibits, posters, workshops and theatres related to their specialty. Rather than depending on the luck of finding the correct information, Artificial Intelligence directs HCPs to content that will deliver maximum benefit.  

For event organisers this is beneficial because it provides greater insight and a broader understanding of what types of content are engaging HCPs and where the greatest number of engaged HCPs are located and how demand varies between therapeutic categories, thus, allowing them to compile data that will aid in planning for future scientific programming, KOL engagements and educational strategies related to market education.  

Personalisation is not merely a convenience but rather a mechanism that drives greater learning after the event and delivers a greater impact overall. 

Compliance and Secure Engagement Workflows 

Digital-first systems have made pharma engagements easier and more discoverable; however, compliance has always been a priority and should remain that way. As a direct result of digital-first systems, there is now a high level of security associated with the way UAE pharma events are conducted.    

UAE pharma events now have the following components:  

• Verified attendance tracking that ensures that only the appropriate specialties access restricted or high-level content  
• Specialty-level gating to protect sensitive scientific or promotional content  
• Compliance-ready records of interactions that document booth visits, workshop participation, and content access in a structured and audit-friendly format.   

The components not only support ethical engagement; they also fulfil the UAE regulatory framework for responsible and secure data use and for communications.     

Digital systems generate interaction logs that can be used as part of internal audits, cross-checked against MLR (medical, legal and regulatory) approvals and/or used as verification of participation in continuing medical education (CME).   

As a result, greater control, clearer documentation and a more streamlined process for governance can occur without slowing the attendee’s experience. 

Samaaro Spotlight – Orchestrating Compliant, Digital-First HCP Journeys 

Pharmaceutical teams in the UAE are under increasing pressure to deliver scientifically meaningful engagement while maintaining strict regulatory discipline. Samaaro is designed to support this balance by enabling digital-first HCP engagement that is structured, secure, and fully auditable. 

Rather than treating events as isolated touchpoints, Samaaro allows pharma organisations to manage HCP engagement as a continuous journey, before, during, and after scientific meetings. 

With Samaaro, teams can: 

• Control access with precision 
  Role- and specialty-based permissions ensure HCPs, speakers, and internal teams only see content appropriate to their profile, reducing compliance risk while preserving relevance. 
• Personalise scientific education responsibly 
  AI-driven recommendations surface sessions, learning modules, and materials aligned to an HCP’s therapeutic focus, past participation, and learning history, without crossing promotional boundaries. 
• Maintain audit-ready engagement records 
  Every interaction, session attendance, workshop participation, content access, and digital touchpoint, is logged securely, creating a transparent trail that supports MLR review, internal audits, and CME verification. 
• Generate insight without compromising governance 
  Integrated analytics combine behavioural engagement with HCP segmentation (specialty, practice setting, region), helping teams understand what content resonates while staying within approved engagement frameworks. 

By combining secure workflows with intelligent personalisation, Samaaro enables pharma enterprises to meet regulatory expectations while delivering the relevance, convenience, and credibility that HCPs in the UAE now expect from digital-first engagement. 

Digital Engagement Is the New Pharma Standard 

The pharmaceutical event climate within the UAE is going through an evolution as it develops into the more digital-driven era of tomorrow. Health care providers (HCPs) are now looking for early access to scientific information, customised agendas and consistent compliance-related interactions. With digital-first approaches, pharma brands will be able to create a more efficient, relevant and accountable environment for scientific exchange. 

Pharma companies that invest in creating these digital capabilities will develop greater trust with their audience through better education and remain competitive in a rapidly changing environment. 

Digital engagement does not replace traditional events; it is used to improve traditional events, creating an enhanced and customised environment in which to have a more meaningful experience.